Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty
A possible association between cytomegalovirus (CMV) infection and restenosis was investigated in a subgroup of patients from the VERAS trial, which was designed to study the effect of octreotide on coronary restenosis after percutaneous transluminal coronary angioplasty.
Saved in:
Published in | The Lancet (British edition) Vol. 350; no. 9086; p. 1225 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Elsevier Ltd
25.10.1997
Lancet Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A possible association between cytomegalovirus (CMV) infection and restenosis was investigated in a subgroup of patients from the VERAS trial, which was designed to study the effect of octreotide on coronary restenosis after percutaneous transluminal coronary angioplasty. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 |
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(05)63456-3 |